Cargando…
Modular nanoarray vaccine for SARS-CoV-2
The current vaccine development strategies for the COVID-19 pandemic utilize whole inactive or attenuated viruses, virus-like particles, recombinant proteins, and antigen-coding DNA and mRNA with various delivery strategies. While highly effective, these vaccine development strategies are time-consu...
Autores principales: | Zagorski, Karen, Pandey, Kabita, Rajaiah, Rajesh, Olwenyi, Omalla A., Bade, Aditya N., Acharya, Arpan, Johnston, Morgan, Filliaux, Shaun, Lyubchenko, Yuri L., Byrareddy, Siddappa N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468299/ https://www.ncbi.nlm.nih.gov/pubmed/36113829 http://dx.doi.org/10.1016/j.nano.2022.102604 |
Ejemplares similares
-
Peptide Nanoarray Scaffold Vaccine for SARS-COV-2 and Its Variants of Concerns
por: Zagorski, Karen, et al.
Publicado: (2022) -
Mental Health Issues During and After COVID-19 Vaccine Era
por: Pandey, Kabita, et al.
Publicado: (2021) -
Diminished Peripheral CD29hi Cytotoxic CD4+ T Cells Are Associated With Deleterious Effects During SIV Infection
por: Olwenyi, Omalla A., et al.
Publicado: (2021) -
Chronic Morphine Administration Differentially Modulates Viral Reservoirs in a Simian Immunodeficiency Virus SIVmac251-Infected Rhesus Macaque Model
por: Acharya, Arpan, et al.
Publicado: (2021) -
Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis
por: Johnson, Samuel D, et al.
Publicado: (2021)